Which antibiotics work best for lung infections? new study compares options
NCT ID NCT06787885
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at 80 people with empyema, a serious lung infection. Researchers compared two different antibiotic combinations to see which was safer and more effective. The goal is to help doctors choose the best treatment for this condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Levofloxacin, clindamycin, cefipime
- What this could lead to
- If successful, this could help doctors choose the most effective antibiotic combination for empyema, improving recovery and reducing side effects.
- What could go wrong
- This is a small, completed study with no phase designation, so results may not apply broadly. Antibiotic resistance or individual patient factors could limit effectiveness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EMPYEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fayoum University hospital
Al Fayyum, Faiyum Governorate, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple antiseptic wash beat chest infections without surgery?
- Can saline alone treat lung infections? new pilot study aims to find out
- Flushing chest tubes may speed recovery from serious lung infections
- New drug cocktail could simplify treatment for dangerous lung lining infection
- Saline vs. drugs: a simpler way to treat lung infections?
- Tiny study checks antibiotic levels in lung infection fluid